# Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)

> **NCT03022968** · PHASE2 · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 17 (actual)

## Conditions studied

- Alzheimer Disease
- Benson's Disease

## Interventions

- **DRUG:** [18F]T807 PET

## Key facts

- **NCT ID:** NCT03022968
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-10
- **Primary completion:** 2019-08-27
- **Final completion:** 2019-11-25
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022968, "Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03022968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*